Table 2.
Respiratory Symptoms and Health-Related Quality of Life Associated with Sarcopenic Obesity in Patients with COPD
| Variable | NBC (n = 66) |
Obesity (n = 59) |
Sarcopenia (n = 54) |
Sarcopenic Obesity (n = 19) |
P-value |
|---|---|---|---|---|---|
| mMRC score | 0.84 ± 0.99 | 1.59 ± 1.26* | 1.90 ± 1.24* | 3.09 ± 1.04*, #, & | < 0.001 |
| CAT scores | 10.69 ± 6.73 | 12.81 ± 7.18 | 16.26 ± 9.53* | 23.30 ± 8.37*, #, & | < 0.001 |
| SGRQ | |||||
| SGRQ activity score | 25.47 ± 18.90 | 26.65 ± 23.46 | 36.35 ± 23.28 | 53.33 ± 18.04*, #, & | 0.006 |
| SGRQ impact score | 10.61 ± 11.88 | 18.29 ± 17.41 | 25.64 ± 13.38* | 66.40 ± 14.40*, #, & | < 0.001 |
| SGRQ symptoms score | 19.44 ± 13.70 | 26.65 ± 23.46 | 39.29 ± 21.78* | 63.00 ± 14.74*, #, & | < 0.001 |
| Total score | 17.00 ± 13.86 | 25.29 ± 20.33 | 32.53 ± 16.47* | 58.17 ± 14.11*, #, & | < 0.001 |
NBC, Normal Body Composition; mMRC, modified Medical Research Council dyspnea scale
Values are given as percentage, mean (SD), or median (interquartile range) and χ2, 1-way ANOVA, or Kruskal–Wallis ANOVA on Ranks P values are indicated respectively, as appropriate
*P < 0 0.05 compared with normal body composition
#P < 0.05 compared with obesity
&P < 0.05 compared with sarcopenia